Essential Medicines Strategic Stockpile Act of 2020
Official title: To amend the Public Health Service Act to provide for stockpiles to ensure that all Americans have access to generic drugs at risk of shortage, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
Essential Medicines Strategic Stockpile Act of 2020
This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.
Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.
The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8479: Essential Medicines Strategic Stockpile Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-8479/
"H.R. 8479: Essential Medicines Strategic Stockpile Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-8479/.
H.R. 8479, 116th Cong. (2026), https://openamerica.io/bill/116-HR-8479/.
[H.R. 8479: Essential Medicines Strategic Stockpile Act of 2020](https://openamerica.io/bill/116-HR-8479/)